{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:57:32Z","timestamp":1791640652529,"version":"4.3.4"},"reference-count":66,"publisher":"Rockefeller University Press","issue":"4","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":237,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA175112"],"award-info":[{"award-number":["CA175112"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA118113"],"award-info":[{"award-number":["CA118113"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA178730"],"award-info":[{"award-number":["CA178730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA217482"],"award-info":[{"award-number":["CA217482"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001129","name":"Georgia Cancer Coalition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008545","name":"Georgia State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,5]]},"abstract":"<jats:p>Fibrotic tumor stroma plays an important role in facilitating triple-negative breast cancer (TNBC) progression and chemotherapeutic resistance. We previously reported a rationally designed protein (ProAgio) that targets integrin \u03b1v\u03b23 at a novel site. ProAgio induces apoptosis via the integrin. Cancer-associated fibroblasts (CAFs) and angiogenic endothelial cells (aECs) in TNBC tumor express high levels of integrin \u03b1v\u03b23. ProAgio effectively induces apoptosis in CAFs and aECs. The depletion of CAFs by ProAgio reduces intratumoral collagen and decreases growth factors released from CAFs in the tumor, resulting in decreased cancer cell proliferation and apoptotic resistance. ProAgio also eliminates leaky tumor angiogenic vessels, which consequently reduces tumor hypoxia and improves drug delivery. The depletion of CAFs and reduction in hypoxia by ProAgio decreases lysyl oxidase (LOX) secretion, which may play a role in the reduction of metastasis. ProAgio stand-alone or in combination with a chemotherapeutic agent provides survival benefit in TNBC murine models, highlighting the therapeutic potential of ProAgio as a treatment strategy.<\/jats:p>","DOI":"10.1084\/jem.20200712","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T17:02:49Z","timestamp":1612976569000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":57,"title":["Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC"],"prefix":"10.1084","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2695-1635","authenticated-orcid":true,"given":"Malvika","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Biology, Georgia State University, Atlanta, GA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9075-7645","authenticated-orcid":true,"given":"Ravi Chakra","family":"Turaga","sequence":"additional","affiliation":[{"name":"Department of Biology, Georgia State University, Atlanta, GA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1821-2178","authenticated-orcid":true,"given":"Yi","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Biology, Georgia State University, Atlanta, GA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1136-1990","authenticated-orcid":true,"given":"Ganesh","family":"Satyanarayana","sequence":"additional","affiliation":[{"name":"Department of Biology, Georgia State University, Atlanta, GA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0092-5559","authenticated-orcid":true,"given":"Falguni","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Biology, Georgia State University, Atlanta, GA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3409-9240","authenticated-orcid":true,"given":"Zhen","family":"Bian","sequence":"additional","affiliation":[{"name":"Department of Biology, Georgia State University, Atlanta, GA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1587-9316","authenticated-orcid":true,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biology, Georgia State University, Atlanta, GA 1"},{"name":"Harbin Medical University Cancer Hospital, Harbin, People\u2019s Republic of China 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-9350","authenticated-orcid":true,"given":"Li","family":"Sun","sequence":"additional","affiliation":[{"name":"Amoytop Biotech Inc., Xiamen, People\u2019s Republic of China 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2310-7658","authenticated-orcid":true,"given":"Jenny","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Georgia State University, Atlanta, GA 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2460-1631","authenticated-orcid":true,"given":"Zhi-Ren","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biology, Georgia State University, Atlanta, GA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"2023072716141709400_bib1","doi-asserted-by":"publisher","first-page":"41461","DOI":"10.1074\/jbc.M404976200","article-title":"Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells","volume":"279","author":"Antonyak","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2023072716141709400_bib2","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1083\/jcb.201702033","article-title":"Cancer-associated fibroblasts lead tumor invasion through integrin-\u03b23-dependent fibronectin assembly","volume":"216","author":"Attieh","year":"2017","journal-title":"J. Cell Biol."},{"key":"2023072716141709400_bib3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jnci\/djx131","article-title":"Targeted Therapy for Cancer-Associated Fibroblasts: Are We There Yet?","volume":"110","author":"Barnett","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"2023072716141709400_bib4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.coi.2020.03.004","article-title":"Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy","volume":"64","author":"Barrett","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"2023072716141709400_bib5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3835(98)00204-3","article-title":"The impact of extracellular matrix on the chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy","volume":"131","author":"Baumgartner","year":"1998","journal-title":"Cancer Lett."},{"key":"2023072716141709400_bib6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin alpha v beta 3 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science."},{"key":"2023072716141709400_bib7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ncb2756","article-title":"Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts","volume":"15","author":"Calvo","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"2023072716141709400_bib8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature."},{"key":"2023072716141709400_bib9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023072716141709400_bib10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12672-017-0285-6","article-title":"MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression","volume":"8","author":"Christenson","year":"2017","journal-title":"Horm. Cancer."},{"key":"2023072716141709400_bib11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1470-2045(07)70074-8","article-title":"Triple-negative breast cancer: therapeutic options","volume":"8","author":"Cleator","year":"2007","journal-title":"Lancet Oncol."},{"key":"2023072716141709400_bib12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell."},{"key":"2023072716141709400_bib13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41571-019-0216-2","article-title":"Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?","volume":"16","author":"D\u2019Abreo","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2023072716141709400_bib14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10549-010-0855-6","article-title":"Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients","volume":"125","author":"de Kruijf","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"2023072716141709400_bib15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejca.2019.09.002","article-title":"Metabolic crosstalk in the breast cancer microenvironment","volume":"121","author":"Dias","year":"2019","journal-title":"Eur. J. Cancer."},{"key":"2023072716141709400_bib16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.csbj.2018.07.003","article-title":"Biophysics of Tumor Microenvironment and Cancer Metastasis - A Mini Review","volume":"16","author":"Emon","year":"2018","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2023072716141709400_bib17","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/hep.24588","article-title":"Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells","volume":"54","author":"Fingas","year":"2011","journal-title":"Hepatology."},{"key":"2023072716141709400_bib18","doi-asserted-by":"publisher","first-page":"24690","DOI":"10.1074\/jbc.M412979200","article-title":"Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation","volume":"280","author":"Fogelgren","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2023072716141709400_bib19","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"2023072716141709400_bib20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/bcr1796","article-title":"Breast tumour angiogenesis","volume":"9","author":"Fox","year":"2007","journal-title":"Breast Cancer Res."},{"key":"2023072716141709400_bib21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF02505035","article-title":"Detection of lysyl oxidase gene expression in rat skin during wound healing","volume":"288","author":"Fushida-Takemura","year":"1996","journal-title":"Arch. Dermatol. Res."},{"key":"2023072716141709400_bib22","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","article-title":"Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer","volume":"24","author":"Haffty","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"2023072716141709400_bib23","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/s41416-020-1020-6","article-title":"T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting","volume":"123","author":"Hanley","year":"2020","journal-title":"Br. J. Cancer."},{"key":"2023072716141709400_bib24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1475-2867-7-16","article-title":"Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer","volume":"7","author":"Havaki","year":"2007","journal-title":"Cancer Cell Int."},{"key":"2023072716141709400_bib25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cell.2018.01.028","article-title":"A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance","volume":"172","author":"Huelsken","year":"2018","journal-title":"Cell."},{"key":"2023072716141709400_bib26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science."},{"key":"2023072716141709400_bib27","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3892\/ijo.2013.1878","article-title":"Hypoxia inducible factor 1\u03b1-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer","volume":"42","author":"Ji","year":"2013","journal-title":"Int. J. Oncol."},{"key":"2023072716141709400_bib28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10911-007-9050-8","article-title":"Modeling metastatic breast cancer in mice","volume":"12","author":"Jonkers","year":"2007","journal-title":"J. Mammary Gland Biol. Neoplasia."},{"key":"2023072716141709400_bib29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer."},{"key":"2023072716141709400_bib30","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan8247","article-title":"Hypoxic cancer-associated fibroblasts increase NCBP2-AS2\/HIAR to promote endothelial sprouting through enhanced VEGF signaling","volume":"12","author":"Kugeratski","year":"2019","journal-title":"Sci. Signal."},{"key":"2023072716141709400_bib31","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.029447","article-title":"A peek into cancer-associated fibroblasts: origins, functions and translational impact","volume":"11","author":"LeBleu","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"2023072716141709400_bib32","doi-asserted-by":"publisher","first-page":"25812","DOI":"10.1074\/jbc.M114.576934","article-title":"Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis","volume":"289","author":"Li","year":"2014","journal-title":"J. Biol. Chem."},{"key":"2023072716141709400_bib33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00019606-199606000-00008","article-title":"Integrin alpha V beta 3 expression by bone-residing breast cancer metastases","volume":"5","author":"Liapis","year":"1996","journal-title":"Diagn. Mol. Pathol."},{"key":"2023072716141709400_bib34","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/annonc\/mdp062","article-title":"Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer","volume":"20","author":"Linderholm","year":"2009","journal-title":"Ann. Oncol."},{"key":"2023072716141709400_bib35","first-page":"1119","article-title":"Tumour-Endothelial Cell Communications: Important and Indispensable Mediators of Tumour Angiogenesis","volume":"36","author":"Lopes-Bastos","year":"2016","journal-title":"Anticancer Res."},{"key":"2023072716141709400_bib36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10456-012-9253-5","article-title":"Angiogenic properties of myofibroblasts isolated from normal human skin wounds","volume":"15","author":"Mayrand","year":"2012","journal-title":"Angiogenesis."},{"key":"2023072716141709400_bib37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jconrel.2015.08.017","article-title":"Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors","volume":"219","author":"Miao","year":"2015","journal-title":"J. Control. Release."},{"key":"2023072716141709400_bib38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/modpathol.2011.4","article-title":"Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance","volume":"24","author":"Mohammed","year":"2011","journal-title":"Mod. Pathol."},{"key":"2023072716141709400_bib39","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","article-title":"The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment","volume":"10","author":"Monteran","year":"2019","journal-title":"Front. Immunol."},{"key":"2023072716141709400_bib40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejso.2012.01.002","article-title":"The prognostic value of tumour-stroma ratio in triple-negative breast cancer","volume":"38","author":"Moorman","year":"2012","journal-title":"Eur. J. Surg. Oncol."},{"key":"2023072716141709400_bib41","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/756078","article-title":"Extracellular matrix modulates angiogenesis in physiological and pathological conditions","volume":"2014","author":"Neve","year":"2014","journal-title":"BioMed Res. Int."},{"key":"2023072716141709400_bib42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa1011418","article-title":"Iniparib plus chemotherapy in metastatic triple-negative breast cancer","volume":"364","author":"O\u2019Shaughnessy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2023072716141709400_bib43","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"\u00d6hlund","year":"2014","journal-title":"J. Exp. Med."},{"key":"2023072716141709400_bib44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"2023072716141709400_bib45","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ccell.2016.10.018","article-title":"Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment","volume":"30","author":"Park","year":"2016","journal-title":"Cancer Cell."},{"key":"2023072716141709400_bib46","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1158\/0008-5472.CAN-13-0012","article-title":"Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-\u03b2-deficient mouse mammary carcinomas","volume":"73","author":"Pickup","year":"2013","journal-title":"Cancer Res."},{"key":"2023072716141709400_bib47","doi-asserted-by":"publisher","first-page":"24506","DOI":"10.18632\/oncotarget.15534","article-title":"Pirfenidone normalizes the tumor microenvironment to improve chemotherapy","volume":"8","author":"Polydorou","year":"2017","journal-title":"Oncotarget."},{"key":"2023072716141709400_bib48","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"2023072716141709400_bib49","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.celrep.2017.04.005","article-title":"Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases","volume":"19","author":"Rachman-Tzemah","year":"2017","journal-title":"Cell Rep."},{"key":"2023072716141709400_bib50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","article-title":"Hypoxic control of metastasis","volume":"352","author":"Rankin","year":"2016","journal-title":"Science."},{"key":"2023072716141709400_bib51","first-page":"963","article-title":"Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis","volume":"57","author":"Relf","year":"1997","journal-title":"Cancer Res."},{"key":"2023072716141709400_bib52","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tranon.2016.07.002","article-title":"Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer","volume":"9","author":"Ribatti","year":"2016","journal-title":"Transl. Oncol."},{"key":"2023072716141709400_bib53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer."},{"key":"2023072716141709400_bib54","doi-asserted-by":"publisher","first-page":"12574","DOI":"10.1038\/s41598-017-13006-x","article-title":"Cancer-associated fibroblasts support vascular growth through mechanical force","volume":"7","author":"Sewell-Loftin","year":"2017","journal-title":"Sci. Rep."},{"key":"2023072716141709400_bib55","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell."},{"key":"2023072716141709400_bib56","doi-asserted-by":"publisher","first-page":"82889","DOI":"10.18632\/oncotarget.12658","article-title":"Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer","volume":"7","author":"Takai","year":"2016","journal-title":"Oncotarget."},{"key":"2023072716141709400_bib57","doi-asserted-by":"publisher","first-page":"11675","DOI":"10.1038\/ncomms11675","article-title":"Rational design of a protein that binds integrin \u03b1v\u03b23 outside the ligand binding site","volume":"7","author":"Turaga","year":"2016","journal-title":"Nat. Commun."},{"key":"2023072716141709400_bib58","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.2147\/CMAR.S185176","article-title":"The clinical promise of immunotherapy in triple-negative breast cancer","volume":"10","author":"Vikas","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"2023072716141709400_bib59","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1177\/1947601911423940","article-title":"The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis","volume":"2","author":"Vong","year":"2011","journal-title":"Genes Cancer."},{"key":"2023072716141709400_bib60","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3892\/ol.2019.9973","article-title":"Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer","volume":"17","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"key":"2023072716141709400_bib61","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/bjs.1800821012","article-title":"Detection of circulating tumour cells with the magnetic activated cell sorter","volume":"82","author":"Wong","year":"1995","journal-title":"Br. J. Surg."},{"key":"2023072716141709400_bib62","doi-asserted-by":"publisher","first-page":"16369","DOI":"10.1073\/pnas.1113483108","article-title":"Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation","volume":"108","author":"Wong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072716141709400_bib63","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00109-011-0855-y","article-title":"Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis","volume":"90","author":"Wong","year":"2012","journal-title":"J. Mol. Med. (Berl.)."},{"key":"2023072716141709400_bib64","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ncb2743","article-title":"The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis","volume":"15","author":"Zhang","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"2023072716141709400_bib65","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/wrr.12411","article-title":"PKM2 released by neutrophils at wound site facilitates early wound healing by promoting angiogenesis","volume":"24","author":"Zhang","year":"2016","journal-title":"Wound Repair Regen."},{"key":"2023072716141709400_bib66","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1101\/gad.1643308","article-title":"Fibronectin fibrillogenesis regulates three-dimensional neovessel formation","volume":"22","author":"Zhou","year":"2008","journal-title":"Genes Dev."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20200712\/1816545\/jem_20200712.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20200712\/1816545\/jem_20200712.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T16:21:54Z","timestamp":1690474914000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/218\/4\/e20200712\/211769\/Simultaneously-targeting-cancer-associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,5]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20200712","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,9]]},"article-number":"e20200712"}}